glp 1 lose muscle mass GLP-1 weight loss and gain Study finds GLP-1 receptor agonists

HumeCare's Terms are direct on this point: the platform does not prescribe, dispense, or practice medicine in any capacity

The Global Anti-Obesity Drug Market is estimated to be valued at USD 30.58 Bn in 2026 and is expected to reach USD 98.63 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 18.2% from 2026 to 2033

Researchers study MOTS-C for insulin resistance, obesity, exercise performance, and aging - particularly for its role in metabolic regulation and longevity signaling

We aim to help make nutrition and healthy living a part of everyones daily routine and provide innovative products able to adapt to any lifestyle, adding an element of fun to your supplement routine